Dose escalation for non-small cell lung cancer using conformal radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 5, 1997, Pages 1079-1085

  Robertson, John M ^a,c   Ten Haken, Randall K ^a   Hazuka, Mark B ^a   Turrisi, Andrew T ^a   Martel, Mary K ^a   Pu, Anthony T ^a   Littles, J Fred ^a   Martinez, Fernando J ^b   Francis, Isaac R ^a   Quint, Leslie E ^a   Lichter, Allen S ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Conformal radiation therapy; Non small cell lung cancer; Phase I clinical trials; Radiation pneumonitis; Radiation therapy; Three dimensional treatment planning

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RADIATION PNEUMONIA; TREATMENT PLANNING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS, PHASE I; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 0031005470     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00593-7     Document Type: Article

References (36)

1. Anscher, M. S.; Murase, T.; Prescott, D. M.; Marks, L. B.; Reisenbichler, H.; Bentel, G. C.; Spencer, D.; Sherouse, G.; Jirtle, R. L. Changes in plasma TGF β levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 30:671-676; 1994.
2. Armstrong, J. G.; Burman, C.; Leibel, S.; Fontenla, D.; Kutcher, G.; Zelefsky, M.; Fuks, Z. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 26:685-689; 1993.
3. Arriagada, R.; le Chevalier, T.; Quiox, E.; Ruffie, P.; de Cremoux, H.; Douillard, J-Y.; Tarayre, M.; Pignon, J-P.; Laplanche, A. ASTRO plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients. Int. J. Radiat. Oncol. Biol. Phys. 20:1183-1190; 1991.
4. Burman, C.; Kutcher, G. J.; Emami, B.; Goitein, M. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 21:123-135; 1991.
5. Byhardt, R. W.; Martin, L.; Pajak, T. F.; Shin, K. H.; Emami, B.; Cox, J. D. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) - Analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int. J. Radiat. Oncol. Biol. Phys. 27:537-544; 1993.
6. Cox, J. D.; Azarnia, N.; Byhardt, R. W.; Shin, K. H.; Emami, B.; Pajak, T. F. A randomized Phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥69.6 Gy in favorable patients with Radiation Therapy Oncology Group Stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 8:1543-1555; 1990.
7. Curran, W. J.; Moldofsky, P. J.; Solin, L. J. Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function. Cancer 65:2488-2493; 1990.
8. Emami, B.; Lyman, J.; Brown, A.; Coia, L.; Goitein, M.; Munzenrider, J. E.; Shank, M.; Solin, L. J.; Wesson, M. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21:109-122; 1991.
9. Fraass, B. A.; McShan, D. L.; Ten Haken, R. K.; Hutchins, K. M. 3-D treatment planning: V. A fast 3-D photon calculation model. In: Bruinvis, I. A. D., ed. The use of computers in radiation therapy. Amsterdam, The Netherlands: Elsevier Science Publishers BV; 1987:521-525.
10. Glazer, G. M.; Gross, B. H.; Quint, L. E.; Francis, I. R.; Bookstein, F. L.; Orringer, M. B. Normal mediastinal lymph nodes: Number and size according to American Thoracic Society Mapping. AJR 144:261-265; 1985.
11. Graham, M. V.; Purdy, J. A.; Emami, B.; Matthews, J. W.; Harms, W. B. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 33:993-1000; 1995.
12. Gross, N. J. Pulmonary effects of radiation therapy. Ann. Intern. Med. 86:81-92; 1977.
13. Hazuka, M. B.; Turrisi, A. T., III; Lutz, S. T.; Martel, M. K.; Ten Haken, R. K.; Strawderman, M.; Borema, P. L.; Lichter, A. S. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis. Int. J. Radiat. Oncol. Biol. Phys. 27:273-284; 1993.
14. Jack, C. I. A.; Cottier, B.; Jackson, M. J.; Cassapi, L.; Fraser, W. D.; Hind, C. R. K. Indicators of free radical activity in patients developing radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 34:149-154; 1996.
15. Jackson, A.; Kutcher, G. J.; Yorke, E. D. Probability of radiation-induced complications for normal tissues with parallel architecture subject to nonuniform irradiation. Med. Phys. 20:613-625; 1993.
16. Krol, A. D. G.; Aussems, P.; Noordijk, E. M.; Hermans, J.; Leer, J. W. H. Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation? Int. J. Radiat. Oncol. Biol. Phys. 34:297-302; 1996.
17. Kutcher, G. J.; Burman, C. Calculation of complication probability factors for nonuniform normal tissue irradiation: The effective volume method. Int. J. Radiat. Oncol. Biol. Phys. 16:1623-1630; 1989.
18. Kutcher, G. J.; Burman, C.; Brewster, L.; Goitein, M.; Mohan, R. Histogram reduction methods for calculating complication probabilities for 3D treatment planning evaluations. Int. J. Radiat. Oncol. Biol. Phys. 21:137-146; 1991.
19. Lichter, A. S.; Sandler, H. M.; Robertson, J. M.; Lawrence, T. S.; Ten Haken, R. K.; McShan, D. L.; Fraass, B. A. Clinical experience with three-dimensional treatment planning. Sem. Radiat. Oncol. 2:257-266; 1992.
20. Lyman, J. T. Complication probability as assessed from dose volume histograms. Radiat. Res. 104:S13-S19; 1985.
21. Lyman, J. T.; Wolbarst, A. B. Optimization of radiation therapy III. A method of assessing complication probabilities from dose-volume histograms. Int. J. Radiat. Oncol. Biol. Phys. 13:103-109; 1987.
22. Maasilta, P. Radiation-induced lung injury. From the chest physician's point of view. Lung Cancer 7:367-384; 1991.
23. Marks, L. B.; Prosnitz, L. R. Estimation of normal tissue complication probabilities with three-dimensional technology. Int. J. Radiat. Oncol. Biol. Phys. 28:777-779; 1994.
24. Marks, L. B.; Spencer, D. P.; Bentel, G. C.; Ray, S. K.; Sherouse, G. W.; Sontag, M. R.; Coleman, R. E.; Jaszczak, R. J.; Turkington, T. G.; Tapson, V.; Prosnitz, L. R. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 26:659-668; 1993.
25. Martel, M. K.; Ten Haken, R. K.; Hazuka, M. B.; Turrisi, A. T.; Fraass, B. A.; Lichter, A. S. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 28:575-581; 1994.
26. McShan, D. L.; Fraass, B. A.; Lichter, A. S. Full integration of the beam's eye view concept into computerized treatment planning. Int. J. Radiat. Oncol. Biol. Phys. 18:1485-1494; 1990.
27. Niemierko, A.; Goitein, M. Modeling of normal tissue response to radiation: The critical volume model. Int. J. Radiat. Oncol. Biol. Phys. 25:135-145; 1992.
28. Oetzel, D.; Schraube, P.; Hensley, F.; Sroka-Pérez, G.; Menke, M.; Flentje, M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys. 33:455-460; 1995.
29. Perez, C. A. Non-small cell carcinoma of the lung: Dose-time parameters. Cancer Treat. Symp. 2:131-142; 1985.
30. Perez, C. A.; Pajak, T. F.; Rubin, P.; Simpson, J. R.; Mohiuddin, M.; Brady, L. W.; Perez-Tamayo, R.; Rotman, M. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy: Report by the Radiation Therapy Oncology Group. Cancer 59:1874-1881; 1987.
31. Robertson, J. M.; Kessler, M. L.; Lawrence, T. S. Clinical results of three-dimensional conformal irradiation. J. Nat. Cancer Inst. 86:968-974; 1994.
32. Sibley, G. S.; Mundt, A. J.; Shapiro, C.; Jacobs, R.; Chen, G.; Weichselbaum, R.; Vijayakumar, S. The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 33:1001-1007; 1995.
33. Simon, R. M. Design and conduct of clinical trials. In: DeVita, V. T.; Hellman, S.; Rosenberg, S. A., eds. Cancer: Principles and practice of oncology. Philadelphia, PA: Lippincott; 1989:396-420.
34. Ten Haken, R. K.; Martel, M. K.; Kessler, M. L.; Hazuka, M. B.; Lawrence, T. S.; Robertson, J. M.; Turrisi, A. T.; Lichter, A. S. Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int. J. Radiat. Oncol. Biol. Phys. 27:689-695; 1993.
35. Vijayakumar, S.; Myrianthopoulos, L. C.; Rosenberg, I.; Halpern, H. J.; Low, N.; Chen, G. T. Y. Optimization of radical radiotherapy with beam's eye view techniques for non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 21:779-788; 1991.
36. Weisenburger, T. H.; Gail, M. Effects of postoperative me diastinal radiation on completely resected Stage II and Stage III epidermoid cancer of the lung. The Lung Cancer Study Group. N. Engl. J. Med. 315:1377-1381; 1996.